A Heartbreaking Retirement: Unraveling the Story of Eli Iserbyt
The End of a Cycling Career: A Tale of Arterial Woes
January 9, 2026, marked a somber day for the world of professional cycling as Eli Iserbyt, a Belgian cyclocross star, announced his retirement due to a dreaded vascular condition. Iserbyt's emotional video left fans and fellow athletes in tears, as he revealed a year-long battle with iliac artery endofibrosis, a condition that threatened his health and ultimately his career.
"It's been a tough journey," Iserbyt shared on Instagram. "After multiple surgeries and endless rehab, the doctors have advised me to hang up my cycling shoes."
But here's where it gets controversial... Iserbyt's story is not unique. Iliac artery endofibrosis, or IAE, has become a silent threat to many professional cyclists, often leading to early retirements. It's a condition that has sparked debates and raised questions within the cycling community.
The Bête Noire of Cycling
Iserbyt, a two-time U23 CX world champion, joins a growing list of top cyclists who have faced this vascular challenge. While some, like Shirin van Anrooij and Fabio Aru, have successfully returned to racing after treatment, others like Zdenek Stybar and Tayler Wiles were not so fortunate.
"IAE is like a hidden enemy," says Dr. Roel Beelen, a vascular surgeon who has treated many cyclists. "It's an occupational hazard for elite athletes, especially cyclists."
Dr. Beelen explains that the repeated strain on the iliac artery, caused by the intense training and racing demands, can lead to a narrowing of the artery, reducing blood flow to the legs. This not only causes physical pain and discomfort but also significantly impacts a cyclist's performance, especially during intense efforts.
The Impact on Performance: A Traumatic Reality
For sprinters and climbers, the drop in power and endurance is a devastating blow. "It's like running out of fuel mid-race," Dr. Beelen adds. "The body's engine, in this case, the blood flow, is restricted, leaving the athlete powerless."
With the advancement of technology, power meters, and training data, doctors can now detect IAE earlier, but for many, the solution lies in surgery and extensive rehabilitation. For Iserbyt, four surgeries and a year of fighting were not enough to overcome this challenge.
A Career Cut Short: Iserbyt's Legacy
Iserbyt's retirement marks the end of a brilliant cyclocross career. With 54 wins in CX, including two world championships, he was a consistent podium finisher. His colleagues, including Wout van Aert and Mathieu van der Poel, expressed their condolences, understanding the impact of such a diagnosis.
"Iserbyt's story is a reminder of the fragility of an athlete's career," van Aert commented. "We wish him all the best in his recovery and future endeavors."
As Iserbyt navigates his new reality, the cycling community reflects on the impact of IAE and the need for further research and support for athletes facing similar challenges.
What are your thoughts on this issue? Do you think enough is being done to address this occupational hazard in cycling? We'd love to hear your opinions in the comments below!
